SiriusPoint (SPNT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
2 Nov, 2025Executive summary
Achieved strong underwriting performance and double-digit premium growth, with a core combined ratio of 89.1% and operating ROE of 17.9% for Q3 2025 and 16.1% year-to-date, both above the 12%-15% target range.
Net income for Q3 2025 was $90.7M, with book value per common share rising to $17.21, up 15.3% from December 31, 2024.
Announced sale agreements for Armada and Arcadian MGAs for $389M, expected to add over $200M to book value and increase per-share value by $1.75 upon closure.
Received multiple industry awards and a positive outlook upgrade from S&P, AM Best, and Fitch, reflecting improved balance sheet strength and reduced risk profile.
Book value per share increased 6% in Q3 and 16% year-to-date, with further upside expected from announced MGA sales.
Financial highlights
Q3 2025 gross premiums written: $872M (+26% YoY); net premiums written: $665M (+32% YoY); net premiums earned up 17.8% to $647.7M.
Q3 2025 net income attributable to common shareholders was $86.8M; operating net income was $85M, with EPS up 41% to $0.72.
9M 2025 gross premiums written: $2.79B (+16% YoY); net premiums written: $2.12B (+19% YoY); net investment income for nine months was $206M.
Book value per diluted common share (ex. AOCI) increased 12.5% year-to-date to $16.47; tangible book value per diluted share: $15.87.
Annualized return on average common shareholders’ equity was 17.7% for Q3 2025 and 14.5% for the nine months.
Outlook and guidance
Management expects continued premium growth, disciplined underwriting, and further capital optimization, reaffirming a long-term ROE target of 12%-15% post-MGA disposals.
Sale of Armada and Arcadian expected to generate significant pre-tax gains in Q4 2025 and Q1 2026, unlocking $205-210M in off-balance sheet value.
S&P upgraded the outlook to positive, with further upside expected from announced MGA sales.
Plan to use MGA sale proceeds to redeem $200M in preference shares, reducing leverage and financing costs.
Expect Q4 premium growth to align with year-to-date trends, with some seasonality expected.
Latest events from SiriusPoint
- Net income up 141%, premium up 16%, 16.2% ROE, and $100M buyback announced.SPNT
Q4 202519 Feb 2026 - Q2 net income $109.9M, book value up 7.2%, and share buyback authorization at $306.3M.SPNT
Q2 20242 Feb 2026 - Q3 2024 saw improved underwriting, strong investment income, and robust capital strength.SPNT
Q3 202417 Jan 2026 - Ninth straight underwriting profit, 14.6% ROE, and 9.8% book value growth in FY24.SPNT
Q4 20249 Dec 2025 - 2025 AGM features director elections, say-on-pay, auditor approval, and highlights strong 2024 results.SPNT
Proxy Filing2 Dec 2025 - Q2 2025 saw strong premium growth, 17% ROE, and improved combined ratios despite catastrophe losses.SPNT
Q2 202523 Nov 2025 - Q1 2025: 12.9% ROE, strong premium growth, and upgraded ratings despite wildfire losses.SPNT
Q1 202518 Nov 2025